Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-1,215
Closed -$56K 475
2019
Q3
$56K Hold
1,215
﹤0.01% 330
2019
Q2
$53K Hold
1,215
﹤0.01% 335
2019
Q1
$54K Hold
1,215
﹤0.01% 320
2018
Q4
$53K Hold
1,215
﹤0.01% 294
2018
Q3
$54K Hold
1,215
﹤0.01% 338
2018
Q2
$49K Hold
1,215
﹤0.01% 346
2018
Q1
$49K Hold
1,215
﹤0.01% 374
2017
Q4
$52K Hold
1,215
﹤0.01% 394
2017
Q3
$60K Hold
1,215
﹤0.01% 389
2017
Q2
$58K Hold
1,215
﹤0.01% 385
2017
Q1
$55K Hold
1,215
﹤0.01% 389
2016
Q4
$49K Hold
1,215
﹤0.01% 391
2016
Q3
$46K Hold
1,215
﹤0.01% 396
2016
Q2
$51K Hold
1,215
﹤0.01% 406
2016
Q1
$49K Hold
1,215
﹤0.01% 392
2015
Q4
$52K Hold
1,215
﹤0.01% 386
2015
Q3
$58K Hold
1,215
﹤0.01% 375
2015
Q2
$60K Hold
1,215
﹤0.01% 380
2015
Q1
$60K Hold
1,215
﹤0.01% 368
2014
Q4
$55K Hold
1,215
﹤0.01% 373
2014
Q3
$69K Hold
1,215
﹤0.01% 365
2014
Q2
$65K Hold
1,215
﹤0.01% 363
2014
Q1
$64K Hold
1,215
﹤0.01% 360
2013
Q4
$65K Hold
1,215
﹤0.01% 308
2013
Q3
$62K Hold
1,215
﹤0.01% 315
2013
Q2
$63K Buy
+1,215
New +$64.7K ﹤0.01% 316

Other funds holding SNY

Hexavest's SNY Position: Q4 2019 in Review

Hexavest sold out of Sanofi (SNY) in Q4 2019, closing a stake of 1,215 shares — an estimated $56K sold.

Hexavest first reported a position in SNY in Q2 2013 and held it in 26 quarters. The position peaked at $69K in Q3 2014. 532 funds tracked by Wall St. Rank hold SNY as of Q4 2019.

  • Hexavest reported no remaining Sanofi position as of Q4 2019 after selling out during the quarter.
  • Hexavest sold 1,215 Sanofi shares in Q4 2019, an estimated $56K.
  • Hexavest first reported a position in Sanofi in Q2 2013 and held it in 26 quarters.
  • Hexavest's Sanofi position peaked at $69K in Q3 2014.
  • 532 funds tracked by Wall St. Rank held Sanofi as of Q4 2019.

Based on Hexavest's 13F filing for Q4 2019, filed 9 Jan 2020.